Jordan is planning new restrictions including extending a night curfew and closing some businesses, the government said on Monday.
The country posted a near record one-day tally of coronavirus cases, driven by a more contagious variant.
The Health Ministry reported 7,413 new cases and 52 deaths on Monday, taking the total number of infections in the country of 10 million people to 435,130, with the death toll at 4,987.
The capital Amman, where nearly four million people live, recorded 3,929 cases, the highest daily total to date.
Health Minister Nathir Obeidat also announced the closure of outpatient clinics in state hospitals to relieve the pressure amid fast-rising occupancy rates.
The surge in the past two months, blamed on the fast spread of the variant first identified in Britain, has put Jordan’s infection numbers above those of most of its Middle East neighbours and reverses months of success in containing the outbreak.
It forced the government last month to reimpose a lockdown on Fridays and delay the opening of schools, while bringing in stringent restrictions on public gatherings and harsher fines for not wearing masks and ignoring social distancing.
The cabinet is due to unveil tougher measures including extending a night curfew that begins at 9pm and closing some businesses, including nightclubs.
Government spokesman Sakher Dudin told state-owned Al Mamlaka TV that long lockdowns had been ruled out for now.
Businessmen say the economy, already reeling from its worst contraction in decades, can ill afford a long lockdown that would deepen poverty and push record unemployment even higher.
"The next few weeks are critical but there will be tougher restrictions [in coming days]," Mr Dudin said.
The government is accelerating a national inoculation programme to cover a quarter of the population but is facing shortages.
So far only 200,000 doses of the Pfizer- BioNTech vaccine have arrived from an original 2.2 million vaccines it signed for, Mr Dudin said.
Health officials say they also expect more vaccines from AstraZeneca to arrive this month.
